Mr. Aberman joined Pluristem as Chairman & CEO in September 2005. Upon arrival he immediately changed the Company’s strategy towards cellular therapeutics. Mr. Aberman's vision to use the maternal section of the Placenta (Decidua) as a source for cell therapy, combined with Pluristem’s 3D culturing technology, led to the development of a series of unique products. Mr. Aberman has 20 years of experience in marketing and management within the high technology industry. He has held positions as Chief Executive Officer and Chairman in Israel, the USA, Europe, Japan and Korea. He has operated within high-tech global companies in the fields of automatic optical inspection, network security, video over IP, software, chip design and robotics. Mr. Aberman serves as the Chairman of Rose Hitech Ltd., a private investment company. He has served in the past as the Chairman of VLScom Ltd., a private company specializing in video compression for HDTV and video over IP and as a Director of Ori Software Ltd., a company involved in data management. Prior to that, he served as the President and CEO of Elbit Vision Systems (EVSNF.OB), which supplies inspection systems for the microelectronic industry. Mr. Aberman has served as President and CEO of Netect Ltd., specializing in the field of internet security software and was the Co-Founder, President and CEO of Associative Computing Ltd., which developed an associative parallel processor for real-time video processing. He has also served as Chairman of Display Inspection Systems Inc., specializing in laser based inspection machines and as President and CEO of Robomatix Technologies Ltd. (RBMXF.OB). In 1992, Mr. Aberman was awarded the Rothschild Prize for excellence in his field from the President of the State of Israel. Mr. Aberman holds a B.Sc. in Mechanical Engineering from Ben Gurion University in Israel.
Yes, that is me in the picture. Not the young ones! God bless your neighborhood pharmacy and your rubgy field. I would prefer if you did not waste my time. If you boys waste my time, then I will set your magnetar trade(s) on the sirena. Sirenas like those mermaids, they have a lot of liquidity protecting them--so better not to try and contact my singularity.
Former Member of the Business Advisory Board of The School of Business at Dowling College; Former Member of Board of Trustees St. Charles Hospital, Port Jefferson, NY. Former Member of Board of Hohmann & Barnard, Hauppauge, NY, a Berkshire Hathaway company; Chairman of Board of International Lombard Corp. NY. Chairman of Lombard Advisory Services LLC., Delaware, President of Ercona Corp. NY; Former Chairman of Monarch Tyres Ltd., Wolverhampton, England.
From 1973 to 1980 was a Director in the Chamber’s of Commerce of Africa, Italian, French, Hellenic and World Trade Club. Director and founder Gatekeepers of Destiny Foundation. A501.(c) 3.
Have been an investor for 60 years. Last 20 years have concentrated on biotechs. Have been senior exec with Shell and ITT before retiring 30+ years ago. My working areas were finance, informatics and international management. Taught MBA courses in management, informatics and communications. Speak French and Spanish plus some German.
Any opinion(s) expressed in any form by me at Seeking Alpha and/or related websites are strictly my own personal views and ideas. They should never be considered advice of any kind, nor considered to be professional opinions.
You should always seek advice from a qualified professional before embarking upon any plan of trading or investing.
All the Best!
Technical Analysis & Japanese Candlesticks Trader as a full time job, over 15 years of experience, combining with fundamentals and thorough DD to find the best entry & exit points, Biotech sector expert, following this sector for over 4 years, trading the clinical catalyst & following the stocks runup till the catalyst day.
I am a retired globetrotter and former financial manager with a Dow Jones Company. Some health issues, which are now very much "under control" and inspiration from key opinion leaders in the regenerative field, made me study the general theme of regenerative cell- and bio-materials technology for the past 8 years and invest in the sector according to my findings and learning's.
M.E. Garza is one of the founders of the biotech and healthcare sector news portal BioMedReports.com. He believes in getting the news from credible sources on the street and often reaches out to CEOs and newsmakers directly for interviews and discussions about their companies. Since he began publishing in 2008, Garza has built a reputation as a writer and reporter who can move markets. His track record for accurately reporting rumors and alerting readers about developments in the biotech/healthcare sector is unmatched during that time.